An observational study in Venepuncture, sponsored by Charite University, Berlin, Germany. Completed at 1 site in Germany. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2011-09-15.
Sponsored by Charite University, Berlin, Germany · Observational
Evaluation of the AccuVein ® AV 300 vein scanner in clinical routine in a pediatric operation room setting for a 4 weeks period. Assessment of usability, anonymous clinical register of every venepuncture(age, gender, size, weight, punction site, number of attempts, time until successful cannulation, local anaesthesia, general anaesthesia, pain scales: faces pain scale und BPS/BPOS).
For application of drugs and liquids a peripheral venous access is necessary in anaesthesiological procedures.The peripheral venepuncture is a painful procedure and induces a higher level of perioperative stress in children.
The punction of peripheral veins in children can be made difficult by the often distinctive amount of subcutaneous fat or other medical conditions.
The AccuVein ® AV300 vein scanner is a contactless, laser-driven device made for facilitate the search for peripheral veins up to a depth of 7mm. This could lead to a minimization of time until successful puncture and smaller number of failures.
Charite University, Berlin, Germany is the lead sponsor of 836 studies on the registry; 129 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients from 0 to 17 years in a peripoerative setting in the pediatric operation room with need for peripheral venous access.
Exclusion Criteria:
Venepuncture performed with support of the AccuVein 300 vein scanner.
Venepuncture without support of the vein scanner.
time until completion of procedure
minutes until successful puncture and cannulation of peripheral vein
Time frame: Day 1
number of attempts until completion of procedure
number of attempts until successful puncture and cannulation of peripheral vein
Time frame: Day 1
This study is completed, as verified in Sep 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany